We discovered that the majority of FGFR2 fusions/translocations in ICC were predominantly observed in a subtype known as cholangiolocarcinoma, which we refer to as “FGFR2 fusion subtype ICC”. The gene discussed is FGFR2; the disease is intrahepatic cholangiocarcinoma.